Eton Pharmaceuticals (ETON) Shares Outstanding (2017 - 2026)

Eton Pharmaceuticals has disclosed Shares Outstanding (Entity) across 10 years of filings, most recently posting $28.3 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 5.49% year-over-year to $28.3 million; the TTM figure through Jun 2026 stood at $28.3 million (up 5.49% YoY), while the FY2025 annual figure was $27.0 million, up 1.27% from the prior year.
• Shares Outstanding (Entity) came in at $28.3 million for Q2 2026 at Eton Pharmaceuticals, up from $27.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $28.3 million in Q2 2026 to a low of $24.6 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $26.0 million, with a median of $25.7 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) increased 0.59% in 2022 and climbed 5.49% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $25.4 million in 2022, then advanced by 1.32% to $25.7 million in 2023, then increased by 3.97% to $26.7 million in 2024, then rose by 1.27% to $27.0 million in 2025, then rose by 4.6% to $28.3 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $28.3 million in Q2 2026, $27.0 million in Q4 2025, and $26.8 million in Q3 2025.